- Home
- AKTX vs SPRU Comparison
AKTX vs SPRU Comparison
Compare AKTX & SPRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKTX
- SPRU
- Stock Information
- Founded
- AKTX N/A
- SPRU 2008
- Country
- AKTX United States
- SPRU United States
- Employees
- AKTX N/A
- SPRU N/A
- Industry
- AKTX Biotechnology: Pharmaceutical Preparations
- SPRU Auto Parts:O.E.M.
- Sector
- AKTX Health Care
- SPRU Consumer Discretionary
- Exchange
- AKTX Nasdaq
- SPRU Nasdaq
- Market Cap
- AKTX 35.7M
- SPRU 34.9M
- IPO Year
- AKTX N/A
- SPRU N/A
- Fundamental
- Price
- AKTX $0.76
- SPRU $1.82
- Analyst Decision
- AKTX Strong Buy
- SPRU
- Analyst Count
- AKTX 2
- SPRU 0
- Target Price
- AKTX $3.30
- SPRU N/A
- AVG Volume (30 Days)
- AKTX 91.6K
- SPRU 97.5K
- Earning Date
- AKTX 08-13-2025
- SPRU 11-12-2025
- Dividend Yield
- AKTX N/A
- SPRU N/A
- EPS Growth
- AKTX N/A
- SPRU N/A
- EPS
- AKTX N/A
- SPRU N/A
- Revenue
- AKTX N/A
- SPRU $98,396,000.00
- Revenue This Year
- AKTX N/A
- SPRU $2.12
- Revenue Next Year
- AKTX N/A
- SPRU N/A
- P/E Ratio
- AKTX N/A
- SPRU N/A
- Revenue Growth
- AKTX N/A
- SPRU 23.43
- 52 Week Low
- AKTX $0.57
- SPRU $1.13
- 52 Week High
- AKTX $3.85
- SPRU $3.25
- Technical
- Relative Strength Index (RSI)
- AKTX 37.47
- SPRU 71.12
- Support Level
- AKTX $0.75
- SPRU $1.47
- Resistance Level
- AKTX $0.89
- SPRU $1.71
- Average True Range (ATR)
- AKTX 0.07
- SPRU 0.09
- MACD
- AKTX 0.01
- SPRU 0.03
- Stochastic Oscillator
- AKTX 57.86
- SPRU 97.50
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.
About SPRU Spruce Power Holding Corporation
Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.